Australian HIV Observational Database

Australian HIV Observational Database
Name	Australian HIV Observational Database
Established	1999
Type	Cohort study
Location	Australia
Discipline	Medicine, Epidemiology

Australian HIV Observational Database

The Australian HIV Observational Database is a longitudinal clinical cohort capturing data on people living with HIV across Australian states and territories, designed to inform treatment, surveillance, and public health responses. It connects data from hospital clinics, sexual health services, community health centers, and research institutions to track antiretroviral therapy outcomes, resistance, and comorbidities. The project interfaces with national and international bodies to support evidence synthesis and guideline development.

Overview

The Database aggregates patient-level and clinic-level information contributed by investigators affiliated with institutions such as Kirby Institute, Monash University, University of Sydney, University of Melbourne, and University of Queensland. Its network includes collaborations with agencies like Australian Government Department of Health and Aged Care, New South Wales Health, Victorian Department of Health, Queensland Health, and non-governmental organizations such as AIDS Council of New South Wales and AFAO. The cohort informs comparative studies with international consortia including COHERE, IeDEA, World Health Organization, and European AIDS Clinical Society.

History and Development

The Database was initiated in the late 1990s amid technological and therapeutic shifts exemplified by developments at Royal Perth Hospital and St Vincent's Hospital, Sydney following early cohort work like the Multicenter AIDS Cohort Study and the EuroSIDA study. Early leadership included clinicians and epidemiologists from Australian Research Council-funded groups and advisers who previously worked with the Centers for Disease Control and Prevention and the National Institutes of Health. Expansion during the 2000s paralleled guideline revisions by bodies such as the Australian Therapeutic Goods Administration and the Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine.

Objectives and Scope

Primary objectives include monitoring antiretroviral therapy effectiveness, documenting HIV drug resistance, and characterizing comorbidities encountered in aging populations managed at sites including Royal Prince Alfred Hospital, Alfred Hospital, and community clinics in Brisbane, Perth, Adelaide, and Canberra. The scope encompasses virological, immunological, pharmacological, and behavioral endpoints that support policy frameworks set by entities like Australian Institute of Health and Welfare and clinical recommendations from the Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine.

Methodology and Data Collection

Data collection employs standardized case-report forms and electronic health record extraction methods used by clinics within networks such as NSW Health Pathology Laboratory Medicine and laboratory partners like Victorian Infectious Diseases Reference Laboratory. Variables include CD4 counts, HIV viral load, antiretroviral regimens, genotypic resistance, and comorbidity diagnoses coded with input from clinicians at Royal Darwin Hospital and researchers at Burnet Institute. Linkage methods have connected cohort records with registries at Australian Bureau of Statistics and administrative datasets managed by Medicare Australia-linked services, following protocols similar to those used in international projects like Swiss HIV Cohort Study.

Key Findings and Publications

Analyses from the Database have contributed to literature on treatment durability, regimen switching, and the epidemiology of transmitted drug resistance, with publications appearing in journals comparable to The Lancet, Clinical Infectious Diseases, Journal of Infectious Diseases, and AIDS (journal). Results have elucidated trends in life expectancy improvements similar to findings from Antiretroviral Therapy Cohort Collaboration and have informed discussions mirrored in reports by UNAIDS and World Health Organization. The Database has produced collaborative outputs on coinfection with Hepatitis C virus and management strategies related to aging and cardiovascular risk informed by comparisons with D:A:D Study findings.

Governance, Funding, and Ethics

Governance involves steering committees with representatives from academic centers such as University of New South Wales, clinical networks including Sexual Health Clinics Victoria, and patient advocacy groups like National Association of People With HIV Australia. Funding has come through grants and agencies including National Health and Medical Research Council, philanthropic contributions linked to organizations like Lord Mayor's Charitable Foundation, and project support from state health departments. Ethical oversight aligns with institutional human research ethics committees at partner hospitals and follows national frameworks similar to those promulgated by the National Health and Medical Research Council and privacy principles observed by Office of the Australian Information Commissioner.

Impact on Clinical Practice and Policy

Findings have been integrated into clinical practice guidance from the Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine and have informed policymaking at the Australian Government Department of Health and Aged Care level, influencing testing strategies, antiretroviral rollout, and models of integrated care used in jurisdictions such as New South Wales, Victoria, and Queensland. The Database has supported translational initiatives at institutions like Kirby Institute and Burnet Institute and shaped training curricula in infectious diseases at universities including Monash University and University of Sydney.

Category:HIV/AIDS in Australia